A Doctor's Note on a Vaccine

f t # e
Washington, November 16, 2020 | comments

November 16, 2020

Dear Friends,

Monday morning brought good news again for Americans: early data on Moderna’s COVID-19 vaccine candidate shows that it is 94.5% effective in protecting recipients from the coronavirus. The Phase 3 trial was conducted alongside the National Institutes of Health and the Biomedical Advanced Research and Development Authority with the results being observed by the Independent Data Safety Monitoring Board.

Within the next few weeks, Moderna plans to submit an Emergency Use Authorization request for the messenger RNA vaccine candidate with the Food and Drug Administration.

On Friday, President Trump gave an update on the progress of Operation Warp Speed, stating that the United States plans to provide vaccines to 20 million Americans in December.

This positive news could not be more timely. Unfortunately, Texas has surpassed one million COVID-19 cases. While we wait for more therapeutics and vaccines, it remains paramount that we continue to follow Centers for Disease Control and Prevention guidelines to protect one another.

Until next time, this is your doctor’s note.

Congressman Michael C. Burgess, M.D.

f t # e